Ronald J. Ellis Jr., Chief Strategy Officer at Pacira BioSciences, Inc. (PCRX), sold 2,276 shares at $37.87 ($87K) on 2023-06-07, disclosed to the SEC on 2023-06-07.
Open-market sale of $87k PCRX by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.99 | 1,114 | $43K | 49.7% |
| 2 | $37.87 | 1,162 | $44K | 50.3% |
| Total | $38.42 avg | 2,276 | $87K | 100% |